Cardiac sarcoidosis: A review 2011

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 5, 2011, Pages 308-315

  Yeboah, John ^a   Lee, Christopher ^a   Sharma, Om P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac; cardiovascular magnetic resonance; implantable cardioverter defibrillators; sarcoid

Indexed keywords

GADOLINIUM; HLA ANTIGEN CLASS 2; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEART ASSIST DEVICE; HEART DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOCARDIOGRAPHY; REVIEW; SARCOIDOSIS;

BIOPSY; CARDIOMYOPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051793466     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328349637a     Document Type: Review

References (77)

1. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004;83:315-334. (Pubitemid 39541109)
2. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
3. Thomsen TK, Eriksson T. Myocardial sarcoidosis in forensic medicine. Am J Forensic Med Pathol 1999;20:52-56. (Pubitemid 29159887)
4. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-172.
5. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine 2004;83:315-334. (Pubitemid 39541109)
6. Nunes H, Feynet O, Naggara N, et al. Cardiac sarcoidosis. Semin Respir Crit Care Med 2010;31:428-441.
7. Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med 2010;134:1039-1046. A review of the histological differences, arguments for genetic associations of cardiac sarcoidosis as well clinical diagnostic criteria.
8. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 2007;28:22-35. (Pubitemid 46371213)
9. Martin WJ, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med 2004;170:567-571. (Pubitemid 39209141)
10. Reich JM. What is sarcoidosis? Chest 2003;124:367-371. (Pubitemid 36851375)
11. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11(2 pt 1):367-369.
12. Yager JE, Hernandez AF, Steenbergen C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 2005;24:1988-1990. (Pubitemid 41641881)
13. Burke WM, Keogh A, Maloney PJ, et al. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990;336:1579.
14. Mehta D, Lubtiz SA, Frankel Z. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008;133:1426-1435. (Pubitemid 351893001)
15. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005;128:1629-1637. (Pubitemid 41324457)
16. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. Am J Med 1977;63:86-108.
17. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997;134:382-386. (Pubitemid 27431239)
18. Fleming H. Cardiac sarcoidosis. In: James DG, editors. Sarcoidosis and other granulomatous disorders. Dekker: New York. 1994. p. 323.
19. Sekiguchi M, Numao Y, Imai M, et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 1980;44:249-263. (Pubitemid 10058641)
20. Vanga Sr, Vacek J, Berenbom L, Lakkireddy DR. Ventricular tachycardia storm: an atypical presentation of sarcoidosis exacerbation. Indian Pacing Electrophysiol J 2009;9:351-354.
21. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108. (Pubitemid 8146656)
22. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-1010. (Pubitemid 33042612)
23. Reuhl J, Schneider M, Sievert H, et al. Myocardial sarcoidosis as a rare cause of sudden cardiac death. Forensic Sci Int 1997;89:145-153. (Pubitemid 27434695)
24. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-1211. (Pubitemid 9092005)
25. Ozaki T, Ohnuma N, Shimizu N, et al. Cardiac sarcoidosis culminating in severe biventricular failure. Case Reports in Medicine 2009:856785
26. Ayyala US, Nair AP, Padilla ML. Cardiac sarcoidosis. Clin Chest Med 2008;29:493-508. (Pubitemid 351778211)
27. Iwai K, Sekiguti M, Hosoda Y, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994;11:26-31.
28. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998;82:537-540. (Pubitemid 28389961)
29. Ahmad K, Kim YH, Spitzer AR, et al. Total nodal radiation in progressive sarcoidosis. Case report. Am J Clin Oncol 1992;15:311-313.
30. Fine RM. The mechanism of hypercalcemia in sarcoidosis. Int J Dermatol 1987;26:22-23.
31. Gardner DG. Hypercalcemia and sarcoidosis. Am J Med 2001;110:736-737.
32. Sato T, Kanzaki H, Ishida Y, et al. Second left ventricular aneurysm newly developed in a patient with untreated cardiac sarcoidosis. Circ J 2010;74:2477-2478.
33. Sato Y, Matsumoto N, Kunimasa T, et al. Multiple involvements of cardiac sarcoidosis in both left and right ventricles and papillary muscles detected by delayed-enhanced magnetic resonance imaging. Int J Cardiol 2008;130:288-290.
34. Goyal SB, Aragam JR. Cardiac sarcoidosis with primary involvement of the tricuspid valve. Cardiol Rev 2006;14:e12-e13. (Pubitemid 44298014)
35. Gasparovic H, Bueno R, Rybicki FJ, et al. Sarcoidosis of the aortic root. J Thorac Cardiovasc Surg 2004;128:761-762. (Pubitemid 39388936)
36. Weiler V, Redtenbacher S, Bancher C, et al. Concurrence of sarcoidosis and aortitis: case report and review of the literature. Ann Rheum Dis 2000;59:850-853.
37. Abrishami B, O'Connel C, Sharma O. Cardiac sarcoidosis with presentation of large left atrial mass. Curr Opin Pulmon Med 2004;10:397-400. (Pubitemid 39099937)
38. Numata S, Kanda K, Hatta T, et al. Sarcoidosis with double saccular abdominal aortic aneurysms. J Vasc Surg 2005;41:1065-1066.
39. Gedalia A, Shetty AK, Ward K, et al. Abdominal aortic aneurysm associated with childhood sarcoidosis. J Rheumatol 1996;23:757-759. (Pubitemid 26132865)
40. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax 1989;44:391-395. (Pubitemid 19143947)
41. Pesola G, Teirstein AS, Goldman M. Sarcoidois presenting with pericardial effusion. Sarcoidosis 1987;4:42-44.
42. Navaneethan SD, Venkatesh S, Shrivastava R, et al. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med 2005;2:e63-e64.
43. Hiraga, H, Yuwai, K, Hiroe, M, et al. Guidelines for the diagnosis of cardiac sarcoidosis: study report of diffuse pulmonary diseases. Jpn Ministry Health Welfare 1993. pp. 23-24.
44. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis ofcardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-1690. (Pubitemid 40704507)
45. Fuse K. Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis. Jpn Circ J 2000;64:755-759.
46. Terasaki F, Fujita M. Enhanced expression of myeloid-related protein complex in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ J 2007;71:1545-1550. (Pubitemid 47529654)
47. Terasaki F, Ukimura A, Tsukada B, et al. Enhanced expression of type 1 helper T cell cytokines in the myocardium of active cardiac sarcoidosis. Circ J 2008;72:1303-1307.
48. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302. (Pubitemid 29379681)
49. Suzuki T, Kanda T, Kubota S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994;106:1021-1024. (Pubitemid 24309534)
50. Uslu N, Akyol A, Gorgulu S, et al. Heart rate variability in patients with systemic sarcoidosis. Ann Noninvasive Electrocardiol 2006;11:38-42.
51. Fahy GJ, Marwick T, McCreery CJ, et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996;109:62-66. (Pubitemid 26017594)
52. Uemura A, Morimoto S, Kato Y, et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:63-65. (Pubitemid 40444736)
53. Haywood LJ, Sharma OP, Siegel ME, et al. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc 1982;74:959-964. (Pubitemid 13215163)
54. Mañá J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 1997;18:799-811. (Pubitemid 27525442)
55. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-334.
56. Kiuchi S, Teraoka K, Koizumi K, et al. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging 2007;23:237-241. (Pubitemid 46431549)
57. Pandya C, Brunken RC, Tchou P, et al. Detecting cardiac involvement in 2007; sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 2007;29:418-422. (Pubitemid 46231921)
58. Smedema JP, White L, Klopper AJ. FDG-PET and MIBI-Tc SPECT as followup tools in a patient with cardiac sarcoidosis requiring a pacemaker. Cardiovasc J Afr 2008;19:309-310.
59. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-527.
60. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005;185:110-115.
61. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRIto standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-1637. (Pubitemid 41324457)
62. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122:1895-1901. (Pubitemid 36051121)
63. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-1977.
64. Butany J, Bahl NE, Morales K, et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol 2006;15:222-227. (Pubitemid 44038392)
65. Aizer A, Stern EH, Gomes JA, et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005;96:276-282. (Pubitemid 40978589)
66. Matsumoto S, Hirayama Y, Saitoh H, et al. Noninvasive diagnosis of cardiac sarcoidosis using microvolt T-wave alternans. Int Heart J 2009;50:731-739.
67. Takada K, Ina Y, Yamamoto M, et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis 1994;11:113-117. (Pubitemid 24311240)
68. Belhassen B, Pines A, Laniado S. Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. Chest 1989;95:918-920. (Pubitemid 19102911)
69. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-943.
70. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: treatment with the automatic implantable cardioverter defibrillator. Am Heart J 1988;116:557-560.
71. Paz HL, McCormick DJ, Kutalek SP, Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 1994;106:1603-1607. (Pubitemid 24346140)
72. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62. (Pubitemid 351689050)
73. Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 2009;6:189-195.
74. Koplan BA, Soejima K, Baughman K, et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006;3:924-929. (Pubitemid 44103499)
75. Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 2007;26:714-717. (Pubitemid 47001719)
76. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987;6:244-250.
77. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-369.